| Reach Resources Limited (RR1) ORDINARY FULLY PAID |
Materials |
$9 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2024 9:34AM |
$0.011 |
$0.010 |
fallen by
9.09%
|
|
RR1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Reach Resources Ltd filed its quarterly activities and cash flow report for the period ending 30 June 2024.
- Significant new discoveries include high-grade niobium and rare earth targets at Wabli Creek.
- The company successfully raised approximately $2.4 million from a non-renounceable rights issue and Priority Offer.
- Heritage surveys were scheduled and conducted at the Wabli Creek Project with the Burringurrah Aboriginal Corporation.
- The company had $6.014 million in cash and cash equivalents at the end of the quarter.
- Total expenditure on exploration and evaluation was largely attributed to field programs at Wabli Creek and reviewing historical drilling data.
- Payments to related parties, covering directors' fees and superannuation, totaled $53,000 for the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| CurveBeam AI Limited (CVB) ORDINARY FULLY PAID |
Health Care |
$24 |
Trading Halt
|
31 Jul 2024 9:33AM |
$0.235 |
$0.074 |
fallen by
68.51%
|
|
CVB - Price-sensitive ASX Announcement
Full Release
Key Points
- CurveBeam AI Limited requested an immediate back-to-back trading halt.
- The trading halt is requested to manage continuous disclosure obligations.
- The halt period is intended to cover the institutional component of an accelerated entitlement offer.
- The halt will last until the earlier of normal trading on 6 August 2024 or an announcement about the ANREO.
- No specific reasons were given for the trading halt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Riedel Resources Limited (RIE) ORDINARY FULLY PAID |
Materials |
$3 |
Proposed issue of securities - RIE
|
31 Jul 2024 9:32AM |
$0.002 |
$0.032 |
risen by
2,033.33%
|
|
| Respiri Limited (RSH) ORDINARY FULLY PAID |
Health Care |
- |
July 2024 Investor Presentation
|
31 Jul 2024 9:32AM |
$0.029 |
$0.033 |
risen by
13.79%
|
|
| Cadence Capital Limited (CDM) ORDINARY FULLY PAID |
Financials |
$200 |
Update - Notification of buy-back - CDM
|
31 Jul 2024 9:32AM |
$0.715 |
$0.670 |
fallen by
6.29%
|
|
| Global X Nasdaq 100 Covered Call ETF (QYLD) |
Financials |
$19 |
Global X Updated Est. Distribution Announcement - July 2024
|
31 Jul 2024 9:32AM |
$11.230 |
$10.910 |
fallen by
2.85%
|
|
| Global X S&P 500 Covered Call ETF (UYLD) |
Financials |
$9 |
Global X Updated Est. Distribution Announcement - July 2024
|
31 Jul 2024 9:32AM |
$10.940 |
$10.700 |
fallen by
2.19%
|
|
| DroneShield Limited (DRO) ORDINARY FULLY PAID |
Industrials |
$2,650 |
Trading Halt
|
31 Jul 2024 9:32AM |
$1.390 |
$3.030 |
risen by
117.99%
|
|
DRO - Price-sensitive ASX Announcement
Full Release
Key Points
- DroneShield Limited (ASX: DRO) requested a trading halt for its ordinary shares.
- The trading halt is requested pending an announcement regarding a proposed capital raising.
- The trading halt is expected to remain in place until the earlier of the company releasing an announcement about the capital raising outcome or the commencement of trading on Friday, 2 August 2024.
- DroneShield Limited provides AI-based platforms for protection against advanced threats such as drones and autonomous systems.
- Customers of DroneShield include military, intelligence community, government, law enforcement, critical infrastructure, and airports.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Somerset Minerals Limited (SMM) ORDINARY FULLY PAID |
Materials |
$12 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2024 9:31AM |
$0.004 |
$0.018 |
risen by
350%
|
|
SMM - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of the acquisition of the Prescott Project in Nunavut, Canada.
- Initiation of a large airborne geophysical survey at the Prescott Project targeting sedimentary hosted copper deposits or Mississippi Valley-Type deposits.
- Identification of a 4 km north-south elongated gravity anomaly high at the Miguel prospect.
- Execution of a Purchase Agreement with Barrick Gold for the sale of the Valle del Tigre II mineral concession.
- Company changed its name to Somerset Minerals Limited.
- Appointment of Mr. Hansen as Managing Director and Mr. Edwards as Non-Executive Chairman.
- Exploration and Evaluation Expenditure during the Quarter was $168,485.
- Cash and cash equivalents at the end of the quarter were $1,435,783.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Metalicity Limited (MCT) ORDINARY FULLY PAID |
Materials |
- |
Proposed issue of securities - MCT
|
31 Jul 2024 9:30AM |
$0.002 |
$0.031 |
risen by
1,450%
|
|
| Iceni Gold Limited (ICL) ORDINARY FULLY PAID |
Materials |
$23 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2024 9:30AM |
$0.054 |
$0.066 |
risen by
22.22%
|
|
ICL - Price-sensitive ASX Announcement
Full Release
Key Points
- Iceni Gold Limited (ICL) released its Quarterly Activities/Appendix 5B Cash Flow Report for the quarter ending June 2024.
- The report includes a summary of exploration and project development activities.
- The cash flow report details the company's financial position including operating, investing, and financing activities.
- Exploration efforts during the quarter focused on various project areas with significant geological potential.
- Key expenditures were made on drilling, geophysical surveys, and assays.
- The report outlines future plans for continued exploration and resource development.
- There was an increase in exploration activities compared to previous quarters.
- ICL's cash position and financial management strategies are highlighted in the Appendix 5B.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Metalicity Limited (MCT) ORDINARY FULLY PAID |
Materials |
- |
Yundamindra Investor Presentation
|
31 Jul 2024 9:30AM |
$0.002 |
$0.031 |
risen by
1,450%
|
|
| Middle Island Resources Limited (MDI) ORDINARY FULLY PAID |
Materials |
$6 |
Drilling Progress Update Barkly Copper-Gold Super Project
|
31 Jul 2024 9:30AM |
$0.016 |
$0.020 |
risen by
25%
|
|
| Cassius Mining Limited (CMD) ORDINARY FULLY PAID |
Materials |
$15 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2024 9:30AM |
$0.006 |
$0.022 |
risen by
266.67%
|
|
CMD - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash used in operating activities: $440,000
- Cash equivalents at end of period: $609,000
- International arbitration against the Government of Ghana for damages exceeding USD 275 million
- Exploring opportunities to expand portfolio
- Negotiating third-party litigation funding
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Metalicity Limited (MCT) ORDINARY FULLY PAID |
Materials |
- |
$1 million Placement to Accelerate Yundamindra Gold Project
|
31 Jul 2024 9:30AM |
$0.002 |
$0.031 |
risen by
1,450%
|
|
MCT - Price-sensitive ASX Announcement
Full Release
Key Points
- Firm commitments for $1.0 million placement from sophisticated investors and directors.
- Funds to accelerate exploration at Yundamindra Gold Project.
- Historical and recent drill results indicate potential for large gold deposits.
- Two tranches for the placement: $0.42 million in Tranche 1 and $0.58 million in Tranche 2.
- Directors committing $120,000 to the placement.
- Plans for a 10:1 consolidation of company securities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vital Metals Limited (VML) ORDINARY FULLY PAID |
Materials |
$12 |
Vital Appoints Consultants for Tardiff Scoping Study
|
31 Jul 2024 9:29AM |
$0.003 |
$0.100 |
risen by
3,233.33%
|
|
VML - Price-sensitive ASX Announcement
Full Release
Key Points
- Vital has appointed ERM Consultants Canada Ltd to complete a Scoping Study for the Tardiff deposit.
- The Scoping Study will examine the size and scalability of future production scenarios at Tardiff.
- Tardiff has a Mineral Resource Estimate of 213Mt at 1.17% TREO, containing more than 623,000 tonnes of NdPr.
- An updated MRE is due in CY2024 to include all recent drill results.
- The Scoping Study is on track for completion by the end of CY2024.
- ERM will review previous work, define a saleable product, estimate capital and operating costs, and review environmental information.
- ERM’s work will follow JORC 2012 and National Instrument 43-101 reporting standards.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BETR Entertainment Limited (BBT) ORDINARY FULLY PAID |
Consumer Discretionary |
$318 |
Q4 FY24 Investor Presentation
|
31 Jul 2024 9:29AM |
$0.215 |
$0.310 |
risen by
44.19%
|
|
BBT - Price-sensitive ASX Announcement
Full Release
Key Points
- BlueBet Holdings Ltd. reported Q4 FY24 results.
- Strong performance driven by increased active customers and higher turnover.
- Growth in the Australian market as well as expansion into the US market.
- Continued investment in technology and marketing to drive future growth.
- Revenue growth supported by strategic partnerships and product innovations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Frugl Group Limited (FGL) ORDINARY FULLY PAID |
Information Technology |
- |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2024 9:28AM |
$0.043 |
$0.014 |
fallen by
67.44%
|
|
FGL - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant growth in quarterly receipts totalling $482k, representing a 630% growth compared to Q4 FY2023.
- First consolidated quarterly results including revenue from Trienpont.
- Frugl selected to present at AusTrade Trade Mission in Thailand.
- Advancements in Artificial Intelligence and Machine Learning with new engagements.
- Acquisition of Trienpont International Co. LTD completed in April 2024.
- Strong cash receipts result of $482k in Q4, with full year receipts at $757k.
- Consolidation of Trienpont's revenues into Frugl post-acquisition.
- Frugl's involvement in AI technology applications for various clients.
- Trienpont's new office expansion in Bangkok.
- Secured additional engagements in data analytics within the Australian retail sector.
- Entered into a loan facility agreement with Radium Capital Pty Ltd for $167,000.
- Maintains an undrawn loan facility agreement with Kenny Woo for $1,000,000.
- Entered into a $2 million convertible note facility with Obsidian Global Partners.
- General Meeting of Shareholders approved the consolidation of issued capital.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Immutep Limited (IMM) ORDINARY FULLY PAID |
Health Care |
$382 |
Immutep Quarterly Activities Report and Appendix 4C
|
31 Jul 2024 9:28AM |
$0.338 |
$0.260 |
fallen by
22.96%
|
|
IMM - Price-sensitive ASX Announcement
Full Release
Key Points
- Entered into third and most important clinical trial collaboration and supply agreement with MSD for the pivotal Phase III trial for first-line non-small cell lung cancer.
- Positive results from TACTI-003 Phase IIb trial in first-line head and neck squamous cell carcinoma with efti in combination with KEYTRUDA.
- Encouraging efficacy and safety data from AIPAC-003 Phase II/III trial with efti and paclitaxel in metastatic breast cancer.
- Received positive regulatory feedback regarding the upcoming TACTI-004 Phase III trial.
- Appointed Centre for Human Drug Research to conduct Phase I trial to evaluate IMP761, a LAG-3 agonist antibody for autoimmune diseases.
- Exclusive license agreement signed with Cardiff University for development of an orally available, small molecule anti-LAG-3 therapy.
- Completed A$100.2 million equity underwritten financing.
- Extended cash runway to end of 2026 with a strong cash and term deposit position of approximately A$181.8 million.
- TACTI-004 Phase III trial will enroll approximately 750 patients and address the entire 1L NSCLC market eligible for anti-PD-1 therapy.
- Reported positive topline results from TACTI-003 Phase IIb trial in 1L HNSCC with an ORR of ~34% regardless of HPV status and PD-L1 expression.
- The investigator-initiated INSIGHT-003 and INSIGHT-005 trials continued to enroll patients with updates expected in CY2024.
- EFTISARC-NEO Phase II trial in Soft Tissue Sarcoma showed no new safety findings and encouraging early efficacy data.
- Entered into agreement with CHDR for first-in-human study of IMP761 expected to enroll participants in Q3 CY2024.
- Exclusive License Agreement with Cardiff University aims to develop low-cost, orally available anti-LAG-3 treatments for cancer patients.
- Reported strong financials with net cash from financing activities of approximately A$95.7 million for the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BETR Entertainment Limited (BBT) ORDINARY FULLY PAID |
Consumer Discretionary |
$318 |
Quarterly Activities Report
|
31 Jul 2024 9:27AM |
$0.215 |
$0.310 |
risen by
44.19%
|
|
BBT - Price-sensitive ASX Announcement
Full Release
Key Points
- Record quarterly turnover of $162.5 million, up 19.8%
- Net Win of $17.7 million, up 18.8%
- Completion of merger with betr on 1 July 2024
- Cost synergies of $14 million per annum on track
- Successful $20 million placement
- Increase in active customers to 76,300, up 14%
- Termination of Indiana market access agreement
- Cash balance of $26 million as of 30 June 2024
- Strong market expansion in Australia and US
- Focus on profitability and technology enhancements
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Duxton Farms Ltd (DBF) ORDINARY FULLY PAID |
Consumer Staple |
$41 |
Update - Notification of buy-back - DBF
|
31 Jul 2024 9:26AM |
$1.570 |
$1.000 |
fallen by
36.31%
|
|
| Lotus Resources Limited (LOT) ORDINARY FULLY PAID |
Energy |
$463 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2024 9:26AM |
$0.255 |
$0.195 |
fallen by
23.53%
|
|
LOT - Price-sensitive ASX Announcement
Full Release
Key Points
- Lotus Resources Limited signed a Mine Development Agreement (MDA) with the Government of Malawi (GoM) for the Kayelekera project.
- The MDA includes a 10-year stability period with key fiscal terms such as a 5% royalty rate and 30% corporate tax rate.
- The Letlhakane project in Botswana received a Mineral Resource update confirming its large-scale uranium potential.
- Infill drilling at Letlhakane is well advanced, with 79 of 180 RC drill holes completed.
- Lotus is in advanced discussions with nuclear utilities and potential offtakers regarding offtake agreements.
- The company expanded its management team by appointing four experienced resource executives.
- Lotus US trading has been upgraded to the OTCQX Market.
- The company holds a closing cash balance of $34.1 million (unaudited), excluding $15.0 million in restricted cash.
- Lotus withdrew from the non-core Wilconi Nickel Joint Venture to focus on uranium projects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Riedel Resources Limited (RIE) ORDINARY FULLY PAID |
Materials |
$3 |
Proposed issue of securities - RIE
|
31 Jul 2024 9:26AM |
$0.002 |
$0.032 |
risen by
2,033.33%
|
|
| OAR Resources Limited (OAR) ORDINARY FULLY PAID |
Materials |
- |
Becoming a substantial holder
|
31 Jul 2024 9:26AM |
$0.002 |
$0.037 |
risen by
2,366.67%
|
|
| Lotus Resources Limited (LOT) ORDINARY FULLY PAID |
Energy |
$463 |
Mine Development Agreement signed in Malawi
|
31 Jul 2024 9:25AM |
$0.255 |
$0.195 |
fallen by
23.53%
|
|
LOT - Price-sensitive ASX Announcement
Full Release
Key Points
- Lotus Resources Ltd has signed a Mine Development Agreement (MDA) with the Government of Malawi.
- The MDA ensures a 10-year stability period for the fiscal regime governing the Kayelekera uranium mine.
- Key tax terms include a royalty rate of 5% and a corporate tax rate of 30%.
- Relief from Resource Rental Tax and Withholding Tax on dividends to non-residents is provided.
- Exemptions are granted for import and export duties, excise, and VAT on capital goods and specific consumables.
- The agreement includes legal protections such as security of tenure, dispute resolution, and expropriation.
- The MDA aligns with Malawi's economic vision, Malawi 2063.
- Lotus plans to complete offtake negotiations, the FEED program, and project financing.
- Lotus's cash balance is $34.1M as of 30 June 2024.
- Lotus owns an 85% interest in the Kayelekera Uranium Project in Malawi.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
